Cargando…

Initiation of intravitreal aflibercept injection treatment in patients with diabetic macular edema: a review of VIVID-DME and VISTA-DME data

BACKGROUND: Diabetic macular edema (DME) shows a gradual and sustained functional and morphologic response to anti-vascular endothelial growth factor (VEGF) drugs, but the optimal schedule for initiation of anti-VEGF therapy is not known. This study evaluates the treatment response behavior of DME i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ziemssen, Focke, Schlottman, Patricio G., Lim, Jennifer I., Agostini, Hansjürgen, Lang, Gabriele E., Bandello, Francesco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5088462/ https://www.ncbi.nlm.nih.gov/pubmed/27847634 http://dx.doi.org/10.1186/s40942-016-0041-z

Ejemplares similares

Impact of Baseline Central Retinal Thickness on Outcomes in the VIVID-DME and VISTA-DME Studies
por: Midena, Edoardo, et al.
Publicado: (2018)

Impact of baseline Diabetic Retinopathy Severity Scale scores on visual outcomes in the VIVID-DME and VISTA-DME studies
por: Staurenghi, Giovanni, et al.
Publicado: (2018)

Systematic review and mixed treatment comparison of intravitreal aflibercept with other therapies for diabetic macular edema (DME)
por: Korobelnik, Jean-Francois, et al.
Publicado: (2015)

Analysis of DME/DME Navigation Performance and Ground Network Using Stretched-Front-Leg Pulse-Based DME
por: Kim, Euiho
Publicado: (2018)

Early adoption of the fluocinolone acetonide (FAc) intravitreal implant in patients with persistent or recurrent diabetic macular edema (DME)
por: McCluskey, Jessica D, et al.
Publicado: (2019)

Impact of intravitreal injection therapy on contrast sensitivity in patients with nAMD and DME
por: Dieke, Sebastian, et al.
Publicado: (2023)

Aflibercept Does Not Suppress Angiopoietin-2 in Patients With nAMD or DME
por: Avery, Robert L., et al.
Publicado: (2023)

Machine learning techniques for diabetic macular edema (DME) classification on SD-OCT images
por: Alsaih, Khaled, et al.
Publicado: (2017)

The Role of Intravitreal Corticosteroids in the Treatment of DME: Predictive OCT Biomarkers
por: Munk, Marion R., et al.
Publicado: (2022)

Association of treatment adherence with real-life VA outcomes in AMD, DME, and BRVO patients
por: Ehlken, Christoph, et al.
Publicado: (2017)

GRAding of functional and anatomical response to DExamethasone implant in patients with Diabetic Macular Edema: GRADE-DME Study
por: Rodríguez-Valdés, Patricio J., et al.
Publicado: (2021)

Intravitreal Aflibercept versus Laser Photocoagulation in Asian Patients with Diabetic Macular Edema: The VIVID-East Study
por: Chen, You-Xin, et al.
Publicado: (2020)

Detailed analysis of retinal morphology in patients with diabetic macular edema (DME) randomized to ranibizumab or triamcinolone treatment
por: Karst, Sonja G., et al.
Publicado: (2017)

Five-year visual acuity outcomes and injection patterns in patients with pro-re-nata treatments for AMD, DME, RVO and myopic CNV
por: Wecker, Thomas, et al.
Publicado: (2017)

Determination of Factors Influencing the Health Belief Model (HBM) and Adherence to Intravitreal Anti-vascular Endothelial Growth Factor (VEGF) Among Patients With Diabetic Macular Edema (DME)
por: Ting Yih Ling, Jacqueline, et al.
Publicado: (2023)

Changes in metamorphopsia following intravitreal aflibercept injection for diabetic macular edema
por: Murakami, Tomoya, et al.
Publicado: (2022)

Effect of intravitreal aflibercept on recalcitrant diabetic macular edema
por: Klein, Kendra A., et al.
Publicado: (2017)

Intravitreal aflibercept versus intravitreal ranibizumab for the treatment of diabetic macular edema
por: Fouda, Sameh Mosaad, et al.
Publicado: (2017)

DME-DeepLabV3+: a lightweight model for diabetic macular edema extraction based on DeepLabV3+ architecture
por: Bai, Yun, et al.
Publicado: (2023)

One-Year Outcome of Aflibercept Intravitreal Injection in Vitrectomized Eyes with Diabetic Macular Edema
por: Tran, Thi Ha Chau, et al.
Publicado: (2021)

Two-Year Outcome of Aflibercept Intravitreal Injection in Vitrectomized Eyes with Diabetic Macular Edema
por: Tran, Thi Ha Chau, et al.
Publicado: (2022)

Microinvasive pars plana vitrectomy combined with internal limiting membrane peeling versus anti-VEGF intravitreal injection for treatment-naïve diabetic macular edema (VVV-DME study): study protocol for a randomized controlled trial
por: Guo, Haoxin, et al.
Publicado: (2023)

3-year-data of combined navigated laser photocoagulation (Navilas) and intravitreal ranibizumab compared to ranibizumab monotherapy in DME patients
por: Herold, Tina Rike, et al.
Publicado: (2018)

Proliferative Diabetic Retinopathy Events in Patients With Diabetic Macular Edema: Post Hoc Analysis of VISTA and VIVID Trials
por: Do, Diana V., et al.
Publicado: (2022)

The DmeRF System Is Involved in Maintaining Cobalt Homeostasis in Vibrio parahaemolyticus
por: Zhao, Yuxuan, et al.
Publicado: (2022)

Combustion control of DME HCCI using charge dilution and spark assistance
por: Yu, Xiao, et al.
Publicado: (2022)

Automatic Detection of AMD and DME Retinal Pathologies Using Deep Learning
por: Saidi, Latifa, et al.
Publicado: (2023)

Renal thrombotic microangiopathy and nephrotic proteinuria induced by intravitreal injection of aflibercept for diabetic macular edema
por: Kikuchi, Yawara, et al.
Publicado: (2022)

Clinical Application of Intravitreal Aflibercept Injection for Diabetic Macular Edema Comparing Two Loading Regimens
por: Chung, Yoo-Ri, et al.
Publicado: (2023)

Randomized clinical trial comparing intravitreal aflibercept combined with subthreshold laser to intravitreal aflibercept monotherapy for diabetic macular edema
por: Tatsumi, Tomoaki, et al.
Publicado: (2022)

Intravitreal ziv-aflibercept for macular edema following retinal vein occlusion
por: Paulose, Remya, et al.
Publicado: (2016)

Comparisons of Efficacy of Intravitreal Aflibercept and Ranibizumab in Eyes with Diabetic Macular Edema
por: Shimizu, Norihiro, et al.
Publicado: (2017)

Therapeutic effect of simultaneous intravitreal dexamethasone and aflibercept on diabetic macular edema
por: Lin, Tai-Chi, et al.
Publicado: (2021)

The Fundus Structural and Functional Predictions of DME Patients After Anti-VEGF Treatments
por: Xie, Hang, et al.
Publicado: (2022)

Assessing the Suitability of DME for Powering SI Engines by Analyzing In-Cylinder Pressure Change
por: Fabiś, Paweł
Publicado: (2022)

Evaluation of microaneurysms as predictors of therapeutic response to anti-VEGF therapy in patients with DME
por: Hatano, Makoto, et al.
Publicado: (2022)

Cost-effectiveness of ranibizumab in treatment of diabetic macular oedema (DME) causing visual impairment: evidence from the RESTORE trial
por: Mitchell, Paul, et al.
Publicado: (2012)

Therapeutic effect of cataract surgery with simultaneous intravitreal injection of aflibercept on diabetic macular edema: An observational study
por: Yen, Chu-Yu, et al.
Publicado: (2022)

Correction: Renal thrombotic microangiopathy and nephrotic proteinuria induced by intravitreal injection of aflibercept for diabetic macular edema
por: Kikuchi, Yawara, et al.
Publicado: (2022)

Switching to Aflibercept in Diabetic Macular Edema Not Responding to Ranibizumab and/or Intravitreal Dexamethasone Implant
por: Herbaut, Antoine, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_do2lpufip3uejlqsnnfu18rt7i